Holly Sundberg-Malek

Affiliations

Center for Personalized Medicine, Eberhard-Karls University, 72076, Tuebingen, Germany.

Publications (1)

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma.

Nature communications

Avec: Stephan Spahn , Fabian Kleinhenz , Ekaterina Shevchenko , Aaron Stahl , Yvonne Rasen , Christine Geisler , Kristina Ruhm , Marion Klaumuenzer , Thales Kronenberger , Stefan A Laufer , Khac Cuong Bui , Marius Horger , Saskia Biskup , Klaus Schulze-Osthoff , Markus Templin , Nisar P Malek , Antti Poso , Michael Bitzer

Réseau de co-auteurs

Stephan Spahn 1 collaboration

Fabian Kleinhenz 1 collaboration

Ekaterina Shevchenko 1 collaboration

Aaron Stahl 1 collaboration

Yvonne Rasen 1 collaboration

Christine Geisler 1 collaboration

Kristina Ruhm 1 collaboration

Marion Klaumuenzer 1 collaboration

Thales Kronenberger 1 collaboration

Stefan A Laufer 1 collaboration

Khac Cuong Bui 1 collaboration

Marius Horger 1 collaboration

Saskia Biskup 1 collaboration

Klaus Schulze-Osthoff 1 collaboration

Markus Templin 1 collaboration

Nisar P Malek 1 collaboration

Antti Poso 1 collaboration

Michael Bitzer 1 collaboration